Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry Letters|November 7, 2002
Design and synthesis of 6-substituted amino-4-oxa-1-azabicyclo[3,2,0]heptan-7-one derivatives as cysteine proteases inhibitorsNian E Zhou, Deqi Guo, Jadwiga Kaleta, et al.Bioorganic & Medicinal Chemistry Letters|May 20, 2008
Use of receptor chimeras to identify small molecules with high affinity for the dynorphin A binding domain of the kappa opioid receptorVirendra Kumar, Deqi Guo, Michael Marella, et al.Bioorganic & Medicinal Chemistry Letters|December 7, 2002
3-Acylamino-azetidin-2-one as a novel class of cysteine proteases inhibitorsNian E Zhou, Deqi Guo, George Thomas, et al.Bioorganic & Medicinal Chemistry Letters|February 17, 2005
Amino acid conjugates as kappa opioid receptor agonistsVirendra Kumar, Deqi Guo, Jeffrey D Daubert, et al.Bioorganic & Medicinal Chemistry Letters|December 20, 2003
P3 cap modified Phe*-Ala series BACE inhibitorsShu-Hui Chen, Jason Lamar, Deqi Guo, et al.Bioorganic & Medicinal Chemistry Letters|December 20, 2003
P1 and P3 optimization of novel bicycloproline P2 bearing tetrapeptidyl alpha-ketoamide based HCV protease inhibitorsFrantz Victor, Jason Lamar, Nancy Snyder, et al.Bioorganic & Medicinal Chemistry Letters|December 20, 2003
Phe*-Ala-based pentapeptide mimetics are BACE inhibitors: P2 and P3 SARJason Lamar, Jingdan Hu, Ana Belen Bueno, et al.Bioorganic & Medicinal Chemistry Letters|February 3, 2005
Synthesis and evaluation of novel peripherally restricted kappa-opioid receptor agonistsVirendra Kumar, Deqi Guo, Joel A Cassel, et al.Nature Communications|May 4, 2026
Characterization of KRASG12C inhibitor olomorasib single-agent and combination with activity in KRASG12C-mutant modelsShengbin Peng, Youyan Zhang, Xi Lin, et al.Pageof 1